Works matching DE "ISOCITRATE dehydrogenase"
Results: 1344
Metabolic adaptation and NADPH homeostasis evoked by a sulfur-deficient environment in Pseudomonas fluorescens.
- Published in:
- Antonie van Leeuwenhoek, 2020, v. 113, n. 5, p. 605, doi. 10.1007/s10482-019-01372-7
- By:
- Publication type:
- Article
Fractal dimension and lacunarity measures of glioma subcomponents are discriminative of the grade of gliomas and IDH status.
- Published in:
- NMR in Biomedicine, 2024, v. 37, n. 12, p. 1, doi. 10.1002/nbm.5272
- By:
- Publication type:
- Article
Pediatric-type diffuse low-grade glioma with T2-FLAIR mismatch sign: a case report and literature review.
- Published in:
- Child's Nervous System, 2024, v. 40, n. 8, p. 2271, doi. 10.1007/s00381-024-06487-5
- By:
- Publication type:
- Article
Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations.
- Published in:
- Acta Neuropathologica, 2021, v. 141, n. 6, p. 945, doi. 10.1007/s00401-021-02291-6
- By:
- Publication type:
- Article
FOCAD loss impacts microtubule assembly, G2/M progression and patient survival in astrocytic gliomas.
- Published in:
- Acta Neuropathologica, 2020, v. 139, n. 1, p. 175, doi. 10.1007/s00401-019-02067-z
- By:
- Publication type:
- Article
5-Hydroxymethylcytosine preferentially targets genes upregulated in isocitrate dehydrogenase 1 mutant high-grade glioma.
- Published in:
- Acta Neuropathologica, 2018, v. 135, n. 4, p. 617, doi. 10.1007/s00401-018-1821-3
- By:
- Publication type:
- Article
Functional requirement of a wild-type allele for mutant IDH1 to suppress anchorage-independent growth through redox homeostasis.
- Published in:
- Acta Neuropathologica, 2018, v. 135, n. 2, p. 285, doi. 10.1007/s00401-017-1800-0
- By:
- Publication type:
- Article
Molecular and clinical heterogeneity of adult diffuse low-grade IDH wild-type gliomas: assessment of TERT promoter mutation and chromosome 7 and 10 copy number status allows superior prognostic stratification.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo.
- Published in:
- Acta Neuropathologica, 2017, v. 133, n. 4, p. 629, doi. 10.1007/s00401-017-1677-y
- By:
- Publication type:
- Article
Gain of 12p encompassing CCND2 is associated with gemistocytic histology in IDH mutant astrocytomas.
- Published in:
- Acta Neuropathologica, 2017, v. 133, n. 2, p. 325, doi. 10.1007/s00401-016-1657-7
- By:
- Publication type:
- Article
Mutant IDH1 and thrombosis in gliomas.
- Published in:
- Acta Neuropathologica, 2016, v. 132, n. 6, p. 917, doi. 10.1007/s00401-016-1620-7
- By:
- Publication type:
- Article
Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities.
- Published in:
- Acta Neuropathologica, 2015, v. 130, n. 3, p. 407, doi. 10.1007/s00401-015-1454-8
- By:
- Publication type:
- Article
Diffusely infiltrating astrocytomas: pathology, molecular mechanisms and markers.
- Published in:
- Acta Neuropathologica, 2015, v. 129, n. 6, p. 789, doi. 10.1007/s00401-015-1439-7
- By:
- Publication type:
- Article
IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO.
- Published in:
- Acta Neuropathologica, 2015, v. 129, n. 6, p. 867, doi. 10.1007/s00401-015-1438-8
- By:
- Publication type:
- Article
IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas.
- Published in:
- Acta Neuropathologica, 2015, v. 129, n. 4, p. 585, doi. 10.1007/s00401-015-1398-z
- By:
- Publication type:
- Article
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an 'integrated' diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma.
- Published in:
- Acta Neuropathologica, 2015, v. 129, n. 1, p. 133, doi. 10.1007/s00401-014-1370-3
- By:
- Publication type:
- Article
Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer.
- Published in:
- Nature, 2014, v. 513, n. 7516, p. 110, doi. 10.1038/nature13441
- By:
- Publication type:
- Article
A vaccine targeting mutant IDH1 induces antitumour immunity.
- Published in:
- Nature, 2014, v. 512, n. 7514, p. 324, doi. 10.1038/nature13387
- By:
- Publication type:
- Article
Cancer biology: Targeting cancer metabolism.
- Published in:
- Nature, 2013, v. 496, n. 7444, p. 141, doi. 10.1038/496141b
- Publication type:
- Article
Cancer: A metabolic metamorphosis.
- Published in:
- Nature, 2013, v. 496, n. 7443, p. 38, doi. 10.1038/496038a
- By:
- Publication type:
- Article
Isocitrate Dehydrogenase Defects In Gliomas: PATH For Potential Therapeutics.
- Published in:
- International Journal of High School Research, 2024, v. 6, n. 7, p. 48, doi. 10.36838/v6i7.8
- By:
- Publication type:
- Article
Olutasidenib for Adults with Relapsed or Refractory Acute Myeloid Leukaemia with Isocitrate Dehydrogenase 1 Mutation.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2024, v. 20, n. 1, p. 25, doi. 10.17925/ohr.2024.20.1.6
- By:
- Publication type:
- Article
Targeting Mutant IDH to Treat Low-grade Glioma.
- Published in:
- touchREVIEWS in Oncology & Haematology, 2023, v. 19, n. 2, p. 7, doi. 10.17925/OHR.2023.19.2.3
- By:
- Publication type:
- Article
Evaluation of Neutrophil Lymphocyte Ratio and IDH Mutation in Patients with Glioblastoma.
- Published in:
- Journal of Tepecik Education & Research Hospital / İzmir Tepecik Eğitim ve Araştırma Hastanesi Dergisi, 2023, v. 33, n. 2, p. 210, doi. 10.4274/terh.galenos.2022.59837
- By:
- Publication type:
- Article
Comparative Transcriptome Analysis Identifies Target Genes for Treatment of IDH Wild-type Lower-grade Gliomas.
- Published in:
- Journal of Tepecik Education & Research Hospital / İzmir Tepecik Eğitim ve Araştırma Hastanesi Dergisi, 2023, v. 33, n. 1, p. 100, doi. 10.4274/terh.galenos.2023.60024
- By:
- Publication type:
- Article
Enerji Metabolizması Enzimlerinden İzositrat Dehidrogenazla İlgili Çalışmaların Bibliyometrik Analizi.
- Published in:
- Mersin University School of Medicine Lokman Hekim Journal of History of Medicine & Folk Medicine, 2023, v. 13, n. 2, p. 437, doi. 10.31020/mutftd.1262989
- By:
- Publication type:
- Article
Transcriptome analysis of the dimorphic transition induced by pH change and lipid biosynthesis in Trichosporon cutaneum.
- Published in:
- Journal of Industrial Microbiology & Biotechnology, 2020, v. 47, n. 1, p. 49, doi. 10.1007/s10295-019-02244-9
- By:
- Publication type:
- Article
Metastatic intrahepatic cholangiocarcinoma in a young patient: a multidisciplinary approach to the case.
- Published in:
- Oncolog-Hematolog, 2024, v. 69, n. 4, p. 21
- By:
- Publication type:
- Article
Glioblastoma Vaccines as Promising Immune-Therapeutics: Challenges and Current Status.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 655, doi. 10.3390/vaccines12060655
- By:
- Publication type:
- Article
ADHFE1 is a MYC-linked oncogene that induces metabolic reprogramming and cellular de-differentiation in breast cancer.
- Published in:
- Molecular & Cellular Oncology, 2018, v. 5, n. 5, p. 1, doi. 10.1080/23723556.2018.1432260
- By:
- Publication type:
- Article
ADHFE1 is a MYC-linked oncogene that induces metabolic reprogramming and cellular de-differentiation in breast cancer.
- Published in:
- Molecular & Cellular Oncology, 2018, v. 5, n. 3, p. 1, doi. 10.1080/23723556.2018.1432260
- By:
- Publication type:
- Article
Exploring the regulatory role of isocitrate dehydrogenase mutant protein on glioma stem cell proliferation.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2016, v. 20, n. 16, p. 3378
- By:
- Publication type:
- Article
MiR-183 modulates multi-drug resistance in hepatocellular cancer (HCC) cells via miR-183-IDH2/SOCS6-HIF-1α feedback loop.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2016, v. 20, n. 10, p. 2020
- By:
- Publication type:
- Article
Enhanced lincomycin A production by calcium gluconate feeding in fermentation of Streptomyces lincolnensis.
- Published in:
- Bioresources & Bioprocessing, 2019, v. 6, n. 1, p. N.PAG, doi. 10.1186/s40643-019-0266-4
- By:
- Publication type:
- Article
Who will benefit from vorasidenib? Review of data from the literature and open questions.
- Published in:
- Neuro-Oncology Practice, 2025, v. 12, p. i6, doi. 10.1093/nop/npae104
- By:
- Publication type:
- Article
Role of the tumor board when prescribing mutant isocitrate dehydrogenase inhibitors to patients with isocitrate dehydrogenase-mutant glioma.
- Published in:
- Neuro-Oncology Practice, 2025, v. 12, p. i29, doi. 10.1093/nop/npae100
- By:
- Publication type:
- Article
Financial challenges of being on long-term, high-cost medications.
- Published in:
- Neuro-Oncology Practice, 2025, v. 12, p. i49, doi. 10.1093/nop/npae098
- By:
- Publication type:
- Article
Symptom management in isocitrate dehydrogenase mutant glioma.
- Published in:
- Neuro-Oncology Practice, 2025, v. 12, p. i38, doi. 10.1093/nop/npae088
- By:
- Publication type:
- Article
Foreword.
- Published in:
- Neuro-Oncology Practice, 2025, v. 12, p. i1, doi. 10.1093/nop/npae087
- By:
- Publication type:
- Article
Vorasidenib: Patient and caregiver information sheet.
- Published in:
- Neuro-Oncology Practice, 2025, v. 12, p. i26, doi. 10.1093/nop/npae081
- By:
- Publication type:
- Article
Practical management of patients with IDH-mutant glioma in the coming era of mIDH inhibitors: New drugs, new evidence, new guidelines, and new considerations.
- Published in:
- Neuro-Oncology Practice, 2025, v. 12, p. i2, doi. 10.1093/nop/npae076
- By:
- Publication type:
- Article
Glioma resource outreach with support: A program to identify and initiate supportive care interventions for unmet needs among adult lower-grade glioma patients.
- Published in:
- Neuro-Oncology Practice, 2025, v. 12, n. 1, p. 87, doi. 10.1093/nop/npae065
- By:
- Publication type:
- Article
Target delineation for glioblastoma—Is it time to sever historical ties?
- Published in:
- Neuro-Oncology Practice, 2024, v. 11, n. 3, p. 221, doi. 10.1093/nop/npae013
- By:
- Publication type:
- Article
Does the distance to the cancer center affect psycho-oncological care and emergency visits of patients with IDH wild-type gliomas? A retrospective study.
- Published in:
- Neuro-Oncology Practice, 2023, v. 10, n. 5, p. 446, doi. 10.1093/nop/npad023
- By:
- Publication type:
- Article
Association between preoperative neurocognitive status and IDH1 mutation status in high-grade gliomas.
- Published in:
- Neuro-Oncology Practice, 2023, v. 10, n. 2, p. 132, doi. 10.1093/nop/npac077
- By:
- Publication type:
- Article
The predictive value of partial MGMT promoter methylation for IDH-wild-type glioblastoma patients.
- Published in:
- Neuro-Oncology Practice, 2023, v. 10, n. 2, p. 126, doi. 10.1093/nop/npac070
- By:
- Publication type:
- Article
FGFR3 overexpression is a useful detection tool for FGFR3 fusions and sequence variations in glioma.
- Published in:
- Neuro-Oncology Practice, 2021, v. 8, n. 2, p. 209, doi. 10.1093/nop/npaa075
- By:
- Publication type:
- Article
Predictors of early, recurrent, and intractable seizures in low-grade glioma.
- Published in:
- Neuro-Oncology Practice, 2021, v. 8, n. 1, p. 40, doi. 10.1093/nop/npaa054
- By:
- Publication type:
- Article
Antidepressant drug use in glioblastoma patients: an epidemiological view.
- Published in:
- Neuro-Oncology Practice, 2020, v. 7, n. 5, p. 514, doi. 10.1093/nop/npaa022
- By:
- Publication type:
- Article
Isocitrate dehydrogenase 1 mutant glioblastomas demonstrate a decreased rate of pseudoprogression: a multi-institutional experience.
- Published in:
- Neuro-Oncology Practice, 2020, v. 7, n. 2, p. 185, doi. 10.1093/nop/npz050
- By:
- Publication type:
- Article